Related Experiment Video
Updated: Jul 18, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Neuropeptides as possible targets in sleep disorders
Seiji Nishino1, Nobuhiro Fujiki
1Stanford University School of Medicine, Department of Psychiatry and Behavioural Sciences, Sleep and Circadian Neurobiology Laboratory and Center for Narcolepsy Research, Palo Alto, CA 94304-5489, USA. nishino@stanford.edu
Neuropeptides significantly impact sleep regulation and are implicated in sleep disorders. Targeting these peptidergic systems offers promising new therapeutic strategies for conditions like narcolepsy.
Area of Science:
- Neuroscience
- Pharmacology
- Sleep Medicine
Background:
- Insomnia and hypersomnia are common sleep disorders often managed with traditional medications targeting neurotransmitter systems.
- Acetylcholine, amino acids, lipids, proteins (cytokines), and peptides are recognized modulators of sleep and may play roles in sleep disorder pathophysiology.
- Recent advances in molecular biology have led to the identification of numerous neuropeptides with significant sleep-modulating effects.
Purpose of the Study:
- To review the history of neuropeptide research.
- To discuss the sleep-modulatory effects of various neuropeptides.
- To explore pharmacological therapeutic strategies targeting peptidergic systems for sleep disorders.
Main Methods:
- Literature review on neuropeptide research history.
- Analysis of studies detailing neuropeptide effects on sleep.
- Discussion of therapeutic approaches targeting peptidergic systems.
Main Results:
- The hypocretin/orexin system's impairment is identified as a key factor in narcolepsy.
- Neuropeptides are increasingly recognized for their crucial roles in sleep regulation.
- Hypocretin replacement therapy shows potential for treating narcolepsy.
Conclusions:
- Neuropeptide research has evolved significantly, revealing their importance in sleep.
- Targeting neuropeptide systems presents a novel avenue for developing treatments for sleep disorders.
- Pharmacological interventions focused on peptidergic pathways hold promise for future sleep disorder therapies.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Narcolepsy
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Management of Insomnia
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...

